Search Results - "Tyagi, Kanika"

Role of Cytokines in Chemotherapy-related Cognitive Impairment of Breast Cancer Patients: A Systematic Review by Tyagi, Kanika, Masoom, Md, Majid, Haya, Garg, Aakriti, Bhurani, Dinesh, Agarwal, Nidhi B, Khan, Mohd Ashif

“…Cognitive impairment is one of the most common problems experienced by patients receiving chemotherapy, and evidence suggests that cytokines might play an…”
Get more information

I rely more on self-monitoring of blood glucose than HbA1c to assess diabetes control. Do you? by Tyagi, Kanika

Get full text

I rely more on self-monitoring of blood glucose than HbA 1c to assess diabetes control. Do you? by Tyagi, Kanika

Get full text

Breakthrough COVID19 infections after vaccinations in healthcare and other workers in a chronic care medical facility in New Delhi, India by Tyagi, Kanika, Ghosh, Amerta, Nair, Dipti, Dutta, Koel, Singh Bhandari, Prakash, Ahmed Ansari, Irshad, Misra, Anoop

“…Vaccinations for COVID19 are now open to all adults in India. However, spread of COVID19 infection continues unabated. We aimed to ascertain number of…”
Get full text

Exacerbation of hyperglycemia in patients with type 2 diabetes after vaccination for COVID19: Report of three cases by Mishra, Abha, Ghosh, Amerta, Dutta, Koel, Tyagi, Kanika, Misra, Anoop

Get full text

Dapagliflozin Improves Body Fat Patterning, and Hepatic and Pancreatic Fat in Patients With Type 2 Diabetes in North India by Ghosh, Amerta, Dutta, Koel, Bhatt, Surya Prakash, Gupta, Ritesh, Tyagi, Kanika, Ansari, Irshad Ahmad, Venugopal, Vasantha Kumar, Mahajan, Harsh, Pandey, Ravindra Mohan, Pandey, Shivam, Misra, Anoop

“…Excess hepatic and pancreatic fat may contribute to hyperglycemia. The objective of this study was to examine the effect of dapagliflozin (an SGLT2 inhibitor)…”
Get full text

Marked erythrocytosis during treatment with sodium glucose cotransporter-2 inhibitors-report of two cases by Gupta, Ritesh, Gupta, Aanchal, Shrikhande, Mitu, Tyagi, Kanika, Ghosh, Amerta, Misra, Anoop

“…SGLT-2 inhibitors are known to increase hematocrit. We present two cases with marked asymptomatic erythrocytosis developing after taking SGLT-2 inhibitors. No…”
Get full text

Acanthosis nigricans independently predicts hepatic fibrosis in people with type 2 diabetes in North India by Dutta, Koel, Bhatt, Surya Prakash, Madan, Swati, Ansari, Irshad Ahmad, Tyagi, Kanika, Pandey, Shivam, Misra, Anoop

“…Acanthosis nigricans (AN) is a skin condition characterized by hyperpigmentation and thickening, often found in individuals with insulin resistance. Despite…”
Get full text

Roadblock in application of telemedicine for diabetes management in India during COVID19 pandemic by Ghosh, Amerta, Dutta, Koel, Tyagi, Kanika, Gupta, Ritesh, Misra, Anoop

Get full text

About 1/3rd of north Indian patients less than 50 years of age with type 2 diabetes have high pulse wave velocity indicating high risk of atherosclerosis by Gupta, Ritesh, Tyagi, Kanika, Anoop, Shajith, Ghosh, Amerta, Misra, Anoop

“…Asian Indian patients with type 2 diabetes mellitus (T2DM) have a high cardiovascular risk even at young age. There is a need to assess this increased risk and…”
Get full text

If only lifestyle compliance of Indian patients with diabetes is better, we could have lot less morbidities and deaths by Mittal, Juhi, Arora, Bhavya, Dutta, Koel, Tyagi, Kanika, Gupta, Aanchal

Get full text

Glycemic parameters in patients with new-onset diabetes during COVID-19 pandemic are more severe than in patients with new-onset diabetes before the pandemic: NOD COVID India Study by Ghosh, Amerta, Anjana, Ranjit Mohan, Shanthi Rani, Coimbatore Subramanian, Jeba Rani, Saravanan, Gupta, Ritesh, Jha, Alka, Gupta, Vimal, Kuchay, Mohammad Shafi, Luthra, Atul, Durrani, Suhail, Dutta, Koel, Tyagi, Kanika, Unnikrishnan, Ranjit, Srivastava, Brijendra Kumar, Ramu, Muthu, Sastry, Nadiminty Ganapathi, Gupta, Prasanna Kumar, Umasankari, Ganesan, Jayashri, Ramamoorthy, Mohan, Viswanathan, Misra, Anoop

“…It is not known if new onset diabetes during Coronavirus-19 disease (COVID-19; NOD COVID) is phenotypically or biochemically different than new onset diabetes…”
Get full text

Sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes mellitus and moderate to severe hepatic fibrosis: A retrospective study by Tyagi, Kanika, Madan, Swati, Prakash Bhatt, Surya, Ansari, Irshad Ahmad, Dutta, Koel, Misra, Anoop

“…Sodium-glucose cotransporter-2 inhibitors (SGLT2i) have been shown to decrease hepatic transaminases, steatosis, and in some studies, hepatic fibrosis…”
Get full text

Dipeptidyl peptidase 4 inhibitors linked bullous pemphigoid in patients with type 2 diabetes mellitus: A series of 13 cases by Jha, Alka, Misra, Anoop, Gupta, Ritesh, Ghosh, Amerta, Tyagi, Kanika, Dutta, Koel, Arora, Bhavya, Durani, Suhail

“…Dipeptidyl peptidase 4 (DPP4) inhibitors have increasingly been linked to bullous pemphigoid, but there is paucity of data from India where about 1.85 million…”
Get full text

Exacerbation of hyperglycemia in patients with type 2 diabetes after vaccination for COVID19: Report of three cases by Mishra, Abha, Ghosh, Amerta, Dutta, Koel, Tyagi, Kanika, Misra, Anoop

Get full text